The original success of Sildenafil undeniably transformed the drug landscape, but betting in companies strongly reliant on off-patent versions presents a uncertain picture. While early returns were impressive, the expiration of patents and the appearance of less expensive alternatives have eroded market share. Therefore, a thorough assessment of… Read More